Tubulointerstitial nephritis (TIN) in patients with IBD has been associated with exposure to 5-aminosalicylates (5-ASA) (26, 27), cyclosporine A, tumor necrosis factor-alpha (TNF-α) inhibitors (28) and vedolizumab (29). This evidence concerns the gene TNF and inflammatory bowel disease.